Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00817427 · ClinicalTrials.gov registry record · NA
Sleep Disturbances as a Risk Factor in Chronic Kidney Disease
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00817427 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 40 participants.
The verdict
NCT00817427, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study is designed to determine if either short night time sleep or poor night time sleep could be a risk factor for increasing the rate at which kidney function deteriorates in persons with mild to moderate kidney disease.
Interventions
- OTHER Controls Short sleep
- OTHER CKD- sleep extension
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2008-10 |
| Est. Completion | 2011-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00817427
The ClinicalTrials.gov registry entry for NCT00817427 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Controls Short sleep is the first listed.
NCT00817427 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00817427 about?
NCT00817427 is a clinical study titled "Sleep Disturbances as a Risk Factor in Chronic Kidney Disease". This study is designed to determine if either short night time sleep or poor night time sleep could be a risk factor for increasing the rate at which kidney function deteriorates in persons with mild to moderate kidney disease.
What is the current status of trial NCT00817427?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2008-10. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00817427?
The interventions under investigation include: Controls Short sleep (OTHER), CKD- sleep extension (OTHER).
Who is sponsoring clinical trial NCT00817427?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.